Literature DB >> 25484498

Diagnosing and managing low serum testosterone.

Ana Marcella Rivas1, Zachary Mulkey1, Joaquin Lado-Abeal1, Shannon Yarbrough1.   

Abstract

Measuring testosterone levels became easier in the 1970s, and it wasn't long before levels were being checked in men across all age groups. At that time, several authors reported an age-associated decline of serum testosterone levels beginning in the fourth or fifth decades of life. Other studies found that the decline in testosterone with age might be more related to comorbidities that develop in many aging men. Aggressive marketing campaigns by pharmaceutical companies have led to increased awareness of this topic, and primary care physicians are seeing more patients who are concerned about "low T." Unfortunately, testosterone replacement therapy has not been straightforward. Many men with low testosterone levels have no symptoms, and many men with symptoms who receive treatment and reach goal testosterone levels have no improvement in their symptoms. The actual prevalence of hypogonadism has been estimated to be 39% in men aged 45 years or older presenting to primary care offices in the United States. As the US population ages, this number is likely to increase. This article, targeted to primary care physicians, reviews the concept of late-onset hypogonadism, describes how to determine the patients who might benefit from therapy, and offers recommendations regarding the workup and initiation of treatment.

Entities:  

Year:  2014        PMID: 25484498      PMCID: PMC4255853          DOI: 10.1080/08998280.2014.11929145

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  18 in total

Review 1.  The health of normally aging men: The Massachusetts Male Aging Study (1987-2004).

Authors:  Amy B O'Donnell; Andre B Araujo; John B McKinlay
Journal:  Exp Gerontol       Date:  2004-07       Impact factor: 4.032

2.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

Review 3.  Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?

Authors:  Farid Saad
Journal:  Diabetes Metab Res Rev       Date:  2012-12       Impact factor: 4.876

4.  Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism.

Authors:  Lisa M Caronia; Andrew A Dwyer; Douglas Hayden; Francesca Amati; Nelly Pitteloud; Frances J Hayes
Journal:  Clin Endocrinol (Oxf)       Date:  2013-02       Impact factor: 3.478

Review 5.  Glucocorticoids, stress, and fertility.

Authors:  S Whirledge; J A Cidlowski
Journal:  Minerva Endocrinol       Date:  2010-06       Impact factor: 2.184

6.  Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS).

Authors:  Abdelouahid Tajar; Ilpo T Huhtaniemi; Terence W O'Neill; Joseph D Finn; Stephen R Pye; David M Lee; György Bartfai; Steven Boonen; Felipe F F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Fernand Labrie; Michael E J Lean; Neil Pendleton; Margus Punab; Dirk Vanderschueren; Frederick C W Wu
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

Review 7.  Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis.

Authors:  Giovanni Corona; Giulia Rastrelli; Matteo Monami; Farid Saad; Michaela Luconi; Marcello Lucchese; Enrico Facchiano; Alessandra Sforza; Gianni Forti; Edoardo Mannucci; Mario Maggi
Journal:  Eur J Endocrinol       Date:  2013-05-02       Impact factor: 6.664

8.  Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome.

Authors:  J Rodriguez-Tolrà; J Torremadé; S di Gregorio; L Del Rio; E Franco
Journal:  Andrology       Date:  2013-05-20       Impact factor: 3.842

9.  Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study.

Authors:  Gideon Sartorius; Sasa Spasevska; Amanda Idan; Leo Turner; Elise Forbes; Anna Zamojska; Carolyn A Allan; Lam P Ly; Ann J Conway; Robert I McLachlan; David J Handelsman
Journal:  Clin Endocrinol (Oxf)       Date:  2012-11       Impact factor: 3.478

Review 10.  The relationship between sleep disorders and testosterone in men.

Authors:  Gary Wittert
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

View more
  3 in total

Review 1.  A property-response perspective on modern toxicity assessment and drug toxicity index (DTI).

Authors:  Vaibhav A Dixit; Pragati Singh
Journal:  In Silico Pharmacol       Date:  2021-05-15

2.  Predictive Values of Nocturia and Its Voiding Frequency on the Aging Males' Symptoms.

Authors:  John Wai-Man Yuen; Ivy Yuen-Ping Wong; Peter Ka-Fung Chiu; Jeremy Yuen-Chun Teoh; Chi-Kwok Chan; Chi-Hang Yee; Chi-Fai Ng
Journal:  Int J Environ Res Public Health       Date:  2022-09-15       Impact factor: 4.614

3.  Age-related changes in serum reproductive hormone levels and prevalence of androgen deficiency in Chinese community-dwelling middle-aged and aging men: Two cross-sectional studies in the same population.

Authors:  Shan-Jie Zhou; Ming-Jia Zhao; Yi-Hong Yang; Di Guan; Zhi-Guang Li; Yu-Dang Ji; Bao-Long Zhang; Xue-Jun Shang; Cheng-Liang Xiong; Yi-Qun Gu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.